SARS-CoV-2 Spike Glycoprotein (S Protein RBD Subunit)

CAT.NOUNITPRICE
$145.00

Specifications


Description

The SARS-CoV-2 transmembrane spike glycoprotein (S Protein) forms homotrimers that protrude from the Coronavirus surface and mediates the entry of Coronavirus into host cells.  The RBD or receptor binding domain of the S1 subunit mediates binding to the host cell by recognizing host cell receptors, one of which has recently been identified as ACE2.

Expression products available for SARS-CoV-2 S Protein RBD Subunit:

  • S Protein RBD Lentiviral Vector
  • S Protein RBD Lentivirus
  • S Protein RBD AAV Vector
  • S Protein RBD AAV
  • S Protein RBD Adenovirus
  • S Protein RBD ORF Vector
  • S Protein RBD Protein Vector
  • S Protein RBD Recombinant Protein
SKUCOV002
Gene NameSARS-CoV-2 Spike Glycoprotein (S Protein RBD Subunit)
Insert Size

672bp
ATGAGAGTCC AACCAACAGA ATCTATTGTT AGATTTCCTA ATATTACAAA CTTGTGCCCT TTTGGTGAAG TTTTTAACGC CACCAGATTT GCATCTGTTT ATGCTTGGAA CAGGAAGAGA ATCAGCAACT GTGTTGCTGA TTATTCTGTC CTATATAATT CCGCATCATT TTCCACTTTT AAGTGTTATG GAGTGTCTCC TACTAAATTA AATGATCTCT GCTTTACTAA TGTCTATGCA GATTCATTTG TAATTAGAGG TGATGAAGTC AGACAAATCG CTCCAGGGCA AACTGGAAAG ATTGCTGATT ATAATTATAA ATTACCAGAT GATTTTACAG GCTGCGTTAT AGCTTGGAAT TCTAACAATC TTGATTCTAA GGTTGGTGGT AATTATAATT ACCTGTATAG ATTGTTTAGG AAGTCTAATC TCAAACCTTT TGAGAGAGAT ATTTCAACTG AAATCTATCA GGCCGGTAGC ACACCTTGTA ATGGTGTTGA AGGTTTTAAT TGTTACTTTC CTTTACAATC ATATGGTTTC CAACCCACTA ATGGTGTTGG TTACCAACCA TACAGAGTAG TAGTACTTTC TTTTGAACTT CTACATGCAC CAGCAACTGT TTGTGGACCT AAAAAGTCTA CTAATTTGGT TAAAAACAAA TGTGTCAATT TC

Accession NumberQIV65011.1 (from MT308693.1)
SpeciesSARS-CoV-2
Documents


Supporting Protocol

    MSDS

      QC

        Other
        FAQs


        There are no FAQs for this product yet!
        References


        4
        • Wang, Q., Yu, H., Yu, H., Ma, M., Ma, Y., & Li, R. "miR‑223‑3p/TIAL1 interaction is involved in the mechanisms associated with the neuroprotective effects of dexmedetomidine on hippocampal neuronal cells in�vitro" Molecular Medicine Reports. : (2018). DOI: 10.3892/mmr.2018.9742.
        • Xu, T., He, B. S., Pan, B., Pan, Y. Q., Sun, H. L., Liu, X. X., ... & Wang, S. K. "MiR‐142‐3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer" Journal of Cellular Physiology. : (2019).
        • Zhang, B., Roosmalen, I. A. M., Reis, C. R., Setroikromo, R., & Quax, W. J. "Death receptor 5 is activated by fucosylation in colon cancer cells" The FEBS Journal 286(3):555–571 (2019). DOI: 10.1111/febs.14742.
        • Zhao, Q., Zhao, S., Li, J., Zhang, H., Qian, C., Wang, H., … Zhao, Y. "TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway" Biomedicine & Pharmacotherapy 109:1640–1649 (2019). DOI: 10.1016/j.biopha.2018.10.046.